The definitive directory of contract development and manufacturing organizations (CDMOs), spanning biologics, drug product and formulation, cell and gene therapy, integrated end-to-end services, sterile fill-finish, API and drug substance, and small molecule manufacturing. Curated for biotechs outsourcing production, sponsors sourcing fill-finish, and business development leads mapping capacity.
BioMed Nexus tracks 147 contract development and manufacturing organizations (CDMOs) across 7 categories: biologics, formulation & drug product, cell & gene therapy, integrated & end-to-end, sterile & fill-finish, API & drug substance, and small molecule. The directory covers the largest CDMOs, including Thermo Fisher (Patheon), Lonza, Samsung Biologics, Catalent, FUJIFILM Diosynth and WuXi, alongside specialist manufacturers. Last updated July 2026
Priority placement at the top of the directory, a dedicated landing page, and a featured newsletter segment reaching 65,000+ subscribers. Limited spots available.
Right now, every CDMO in this directory is just a name in a database. Featured partners get a full profile with logo, capabilities, capacity, backlinks, and priority placement at the very top of this page, seen by 65,000+ biotech professionals every week. Claim the top spot before your competitors do.
The BioMed Nexus Contract Development & Manufacturing Organizations (CDMO) Directory is a comprehensive, regularly updated list of contract manufacturers serving the pharma and biotech industry, spanning biologics, formulation and drug product, cell and gene therapy, integrated end-to-end services, sterile fill-finish, API and drug substance, and small molecule manufacturing. It covers the largest global CDMOs alongside specialist manufacturers.
Use it to research CDMOs by modality and capability, shortlist manufacturing partners, and compare large integrated players against specialists. Whether you are a biotech outsourcing production, a sponsor sourcing sterile fill-finish, or a business development lead mapping capacity, the directory provides structured, current CDMO data. Curated and maintained by the BioMed Nexus editorial team; last updated July 2026.
CDMOs can claim a free basic listing or become a Featured Partner for priority placement, a dedicated landing page, backlinks, and a featured segment in the BioMed Nexus daily newsletter reaching 65,000+ subscribers. Contact our partnerships team to learn more.
